Intended for healthcare professionals

Letters Antidepressant use and FDA warnings

Authors’ reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5722 (Published 09 October 2014) Cite this as: BMJ 2014;349:g5722